In the Tashkent City Administrative Court on February 19, an appeal by residents of the "Shaykh Shibl" mahalla was heard regarding a construction project on the former vaccine and serum institute territory.
The initial court decision denied the residents' request to invalidate the construction permit for a residential and business complex. The dispute has been ongoing for years, with concerns raised about potential health risks associated with the construction. Despite residents' efforts, the court ruled in favor of allowing the project to proceed.
The decision has sparked further discontent among the residents, who are considering further legal action to challenge the court's ruling. The complex issue at hand involves balancing the interests of the residents with the development plans of the construction company, Biopharm Plus. The outcome of this case will have significant implications for both the local community and the future of the construction project.
